Sciatica Surgery — Microdiscectomy, PELD, and Surgical Treatment Guide — Cost, Top Hospitals & Success Rates | MyMedicPlus

Sciatica — formally termed lumbar radiculopathy — is pain, numbness, tingling, or weakness radiating along the distribution of the sciatic nerve from the lower back through the buttock and down one or both legs. The most common cause is compression of a lumbar nerve root by a herniated intervertebral disc, most frequently at the L4/L5 or L5/S1 levels. The sciatic nerve, the largest nerve in the human body, is formed from the L4–S3 nerve roots. Disc herniation occurs when the nucleus pulposus prolapses through the annulus fibrosus, mechanically compressing and chemically irritating the adjacent nerve root via inflammatory mediators (phospholipase A2, TNF-α).

Annual incidence of clinically significant sciatica is approximately 5 per 1,000 adults; lifetime prevalence reaches 40%. The majority — approximately 80–90% — of patients with lumbar disc herniation and sciatica improve without surgery within 6–12 weeks with conservative management. Surgical intervention is considered when conservative management has failed after 6 weeks, when neurological deficit is progressive, or when cauda equina syndrome is present.

The landmark SPORT trial (Spine Patient Outcomes Research Trial, JAMA 2006) — the largest RCT of lumbar disc surgery — demonstrated that both surgery and conservative management significantly improve outcomes over 2 years. However, surgical patients achieved substantially faster and greater pain relief, improved ODI disability scores, and superior SF-36 physical function at 3 months and 1 year. The difference attenuates by 2 years in intention-to-treat analysis, though per-protocol analysis continues to favour surgery. This nuance guides shared decision-making — surgery offers accelerated recovery but equivalent long-term outcomes compared to prolonged conservative management in most cases.

Surgical decompression addresses a range of spinal conditions causing lumbar nerve root compression:

• L4/L5 disc herniation: Compresses the L5 nerve root, producing dorsiflexion weakness (foot drop), sensory loss over the lateral foot and first web space, and radiating pain down the lateral leg to the dorsum of the foot.
• L5/S1 disc herniation: Compresses the S1 nerve root, producing plantarflexion weakness, loss of the ankle jerk reflex, sensory loss over the lateral foot and heel, and pain radiating to the sole and lateral foot.
• Cauda equina syndrome (CES): Compression of the cauda equina nerve roots causing bilateral leg weakness, saddle anaesthesia (perineum, inner thighs), and bladder/bowel dysfunction (urinary retention, faecal incontinence). A true surgical emergency requiring decompression within 24–48 hours to prevent permanent neurological deficit.
• Far lateral (extraforaminal) disc herniation: Compresses the exiting nerve root above the interspace; requires specific lateral surgical approach distinct from standard midline microdiscectomy.
• Sequestered disc fragment: Detached nucleus pulposus fragment migrating superiorly or inferiorly in the epidural space; surgical retrieval often necessary as it does not resorb reliably.
• Recurrent disc herniation: At the same level following prior successful surgery; technically more demanding due to epidural scar formation.
• Lumbar spinal stenosis with radiculopathy: Degenerative narrowing of the spinal canal or foramina causing neurogenic claudication; treated with laminectomy or laminotomy.
• Degenerative spondylolisthesis with radiculopathy: Slippage of one vertebra on another, causing foraminal stenosis and radiculopathy; may require decompression plus fusion.

Absolute indication — Cauda Equina Syndrome (CES): Emergency surgical decompression within 24–48 hours of onset of bladder/bowel dysfunction, bilateral radiculopathy, and saddle anaesthesia. Delayed surgery beyond 48 hours is associated with increased risk of permanent bladder, bowel, and sexual dysfunction (Todd NV, Br J Neurosurg 2005). Pre-operative catheterisation and urgent MRI are mandatory.

Relative indications (elective surgery):

• Progressive motor weakness — foot drop at L4/L5, progressive ankle weakness at L5/S1 — that does not improve within 4–6 weeks of conservative management.
• Failure of ≥6 weeks of appropriate conservative management (analgesics at adequate doses, physiotherapy, and at least one selective nerve root block or epidural steroid injection) with ongoing disabling leg-dominant pain.
• Disabling sciatica significantly limiting activities of daily living and affecting quality of life, with positive clinical-radiological correlation (radiculopathy pattern matching MRI disc herniation level).

Pre-operative assessment: MRI lumbar spine is the gold standard imaging, demonstrating disc herniation level, degree of nerve root compression, and any secondary changes. CT myelogram is used when MRI is contraindicated. Surgical level must correlate precisely with the clinical radiculopathy pattern. EMG/NCS is occasionally used to confirm nerve root level in atypical cases. Pre-operative haemoglobin optimisation, smoking cessation advice, and VTE prophylaxis planning are standard. Psychological assessment is valuable to identify patients at risk of failed back surgery syndrome (FBSS) — screening with STarT Back or Keele Tool identifies high-risk patients who may benefit from pre-operative pain psychology input.

Microdiscectomy (Gold Standard): Performed under general anaesthesia in the prone position. A small posterior midline or paramedian skin incision (2–3 cm) is made over the affected level. Using an operative microscope (or surgical loupe magnification), a partial laminectomy and flavectomy expose the epidural space. The nerve root is carefully retracted medially, and the herniated disc fragment is identified and removed using pituitary rongeurs or endplate curettes. Operating time 45–90 minutes; day surgery or 1-night stay in most centres. SPORT trial: surgical patients reported superior leg pain relief, ODI improvement, and SF-36 physical function at 3 months and 1 year; differences converge by 2 years in ITT analysis.

Tubular/Minimally Invasive Microdiscectomy (MIS): Uses a series of dilating retractors (METRx or similar) to create a working channel through paraspinal musculature rather than open exposure. Equivalent clinical outcomes to open microdiscectomy (Arts et al., BMJ 2011) with reduced blood loss, shorter hospital stay, and faster return to work in some studies. Preferred by many surgeons for single-level disc herniation.

Percutaneous Endoscopic Lumbar Discectomy (PELD): Transforaminal or interlaminar approach using an 8 mm working cannula and 25° rod-lens endoscope. Can be performed under local anaesthesia with sedation, allowing intraoperative neural monitoring by patient feedback. Systematic reviews (Lee et al., Pain Med 2015; Yang et al., Spine 2017) demonstrate equivalent clinical outcomes to microdiscectomy — comparable VAS leg pain reduction, ODI improvement, and MacNab outcomes — with significantly smaller incision (<1 cm), reduced blood loss, shorter hospitalisation (often day-case), faster return to work, and lower wound infection rate. Gaining widespread adoption as first-choice minimally invasive approach in high-volume centres.

Lumbar Spinal Fusion (PLIF/TLIF/ALIF): Reserved for disc herniation concurrent with structural instability, degenerative spondylolisthesis, or recurrent herniation requiring structural support after previous discectomy. Adds significantly to recovery time, blood loss, and cost vs discectomy alone.

Automated Percutaneous Lumbar Discectomy (APLD) and Nucleoplasty: For contained disc herniations without sequestration; removes nucleus material to decompress the disc. Limited evidence base versus microdiscectomy; not first-choice in most guidelines.

Surgical decompression for well-selected sciatica patients provides substantial short- and long-term benefits:

• Rapid pain relief: 85–95% of patients achieve satisfactory leg pain relief following microdiscectomy for disc herniation with radiculopathy. The SPORT trial demonstrated VAS leg pain improvement of −3.7 points (surgical group) versus −2.5 points (conservative group) at 3 months — a clinically meaningful advantage.
• Faster functional recovery: Surgical patients return to sedentary work approximately 6–8 weeks post-operatively versus 12–16 weeks for conservative management; physically demanding work at 12 weeks versus 16–24 weeks. ODI functional improvement is superior at 3 months and 1 year.
• Neurological recovery: Motor deficits (foot drop, ankle weakness) recover faster and more completely with early surgical decompression. Cauda equina syndrome decompressed within 48 hours achieves significantly better bladder, bowel, and sexual function outcomes versus delayed surgery.
• PELD advantages: Day-case potential, <1 cm incision, reduced blood loss (<50 mL vs 100–200 mL for open), lower wound complication rate, preserved surrounding musculature, and equivalent clinical outcomes — making it a compelling minimally invasive first choice in appropriate candidates.
• Prevention of permanent deficit: Timely surgery for progressive foot drop or cauda equina syndrome prevents permanent neurological disability. Observation of progressive weakness beyond 4–6 weeks carries risk of incomplete recovery.
• Psychological benefit: Resolution of chronic leg-dominant pain, improved sleep quality, and reduced analgesic dependency significantly improve patient-reported quality of life and mental health outcomes.

Microdiscectomy and lumbar decompression carry well-characterised risks that should be discussed thoroughly during pre-operative consent:

Intraoperative risks: Dural tear with cerebrospinal fluid (CSF) leak occurs in 1–7% — treated with primary repair (Prolene suture) and post-operative flat bed rest; rarely requires blood patch. Vascular injury to anterior vessels (rare: <0.1%) during disc curettage — catastrophic if unrecognised. Nerve root injury (<1%) — risk higher for far lateral disc or revision surgery.

Post-operative complications: Wound infection 1–3% (superficial; treated with antibiotics); deep discitis or epidural abscess <1% (requires prolonged antibiotics, rarely revision). Epidural haematoma (rare; presents as acute neurological deterioration post-op requiring urgent evacuation). Deep vein thrombosis/pulmonary embolism (<1% for discectomy; TED stockings and early mobilisation are standard prophylaxis).

Recurrence: Recurrent disc herniation at the same level occurs in 5–10% of patients — the most common long-term surgical complication. Revision microdiscectomy is technically more demanding due to epidural scar formation. Adjacent segment disease: Degenerative changes at the level above or below develop at approximately 3% per year; risk increases with partial or complete discectomy and is higher in fusion procedures.

Failed back surgery syndrome (FBSS): Persistent or recurrent pain despite anatomically successful surgery — affects 10–40% depending on patient selection. Risk factors include pre-operative psychological distress (high scores on Pain Catastrophizing Scale), multi-level surgery, workers' compensation claims, and duration of symptoms >6 months before surgery. Epidural scar formation (fibrosis) around the nerve root can cause chronic radiculopathy.

Specific to PELD: Incomplete fragment removal requiring conversion to open surgery (2–5%); retained fragment; approach-related dural puncture.

Post-operative recovery for microdiscectomy and PELD follows a structured rehabilitation pathway:

Immediate post-operative period: Early mobilisation is strongly encouraged — walking day of surgery or day 1. Discharge typically day 1–2 (microdiscectomy) or day of surgery (PELD). Wound review at 10–14 days. Clear advice provided on red flag symptoms requiring urgent review: new bilateral leg weakness, saddle anaesthesia, urinary retention or incontinence (cauda equina recurrence).

Physiotherapy and rehabilitation: Initiated at 2–4 weeks post-operatively: McKenzie method for lumbar extension exercises, core stabilisation (transversus abdominis activation), and sciatic nerve mobilisation exercises. Hydrotherapy considered from week 4. Graded return to activity avoids prolonged recumbency (a risk factor for FBSS).

Return to work: Sedentary/office work: 2–4 weeks post-surgery. Light manual work: 6–8 weeks. Heavy manual/physical labour: 10–12 weeks with physiotherapy clearance. Driving: typically from week 2–4 depending on ability to perform an emergency stop safely.

Imaging follow-up: Repeat MRI at 6–12 weeks if symptoms persist or recur after initial improvement (distinguishes recurrent herniation from normal post-operative changes). Note: MRI at 6 weeks routinely shows residual disc material and epidural fibrosis — asymptomatic imaging changes should not prompt further surgery.

Outcomes assessment: VAS leg pain and back pain scores, Oswestry Disability Index (ODI), and SF-36 physical function assessed at 6 weeks, 3 months, 6 months, and 12 months. Annual follow-up if residual neurological deficit, adjacent level degeneration on imaging, or symptoms of recurrence are present. Approximately 85–90% of patients report satisfactory outcome (MacNab 'excellent' or 'good') at 12 months.

The total cost of sciatica surgery varies considerably by geography, surgical approach, and healthcare system:

• USA: Microdiscectomy total episode cost (facility fee + surgeon + anaesthesia + imaging + physiotherapy) USD 15,000–35,000 as a day-case or 1-night inpatient procedure. PELD in specialist centres: similar or lower, benefiting from day-case potential. Lumbar fusion for recurrent herniation/instability: USD 40,000–100,000.
• UK: NHS-funded for patients meeting NICE/GIRFT criteria (failed conservative management + neurological deficit or severe pain). Private UK cost: GBP 6,000–12,000 for microdiscectomy; GBP 8,000–15,000 for PELD in specialist centres.
• Medical tourism destinations: India (USD 3,000–7,000), Thailand (USD 4,000–9,000), Turkey (USD 3,500–7,000), Mexico (USD 4,000–8,000) — all for microdiscectomy including surgeon, anaesthesia, hospital stay, and implants where applicable.
• Additional cost factors: Pre-operative MRI (USD 800–2,500 USA; GBP 400–800 UK private); anaesthesia (USD 1,500–3,000 in the USA for general); inpatient overnight stay (USD 2,000–4,000/night); post-operative physiotherapy (USD 3,000–6,000 for a structured 12-week programme).
• Insurance coverage: Most medical insurance plans cover lumbar microdiscectomy or PELD with documented conservative treatment failure (6 weeks minimum) and positive MRI-clinical correlation. Pre-authorisation and specialist referral are typically required.

The majority of sciatica cases resolve without surgery. The following non-surgical approaches form the foundation of initial management and serve as true alternatives in non-urgent cases:

Conservative management (first 6 weeks):

• NSAIDs: Naproxen, diclofenac, or ibuprofen — first-line analgesics for acute sciatica; modest evidence for symptom relief. Use with gastroprotection (PPI) in those at risk.
• Short-course oral corticosteroids: Methylprednisolone dose pack (Medrol); reduces perineural inflammation; RSSSI trial demonstrated short-term benefit for acute radiculopathy; not recommended long-term.
• Physiotherapy: McKenzie method, neural mobilisation (sciatic nerve flossing), and general conditioning; evidence supports physiotherapy as superior to placebo for function and return to work.
• Activity modification: Early return to normal activities (within pain limits) is superior to strict bed rest, which is no longer recommended.

Interventional non-surgical options:

• Transforaminal epidural steroid injection (TFESI): Most effective for acute/subacute sciatica — short-term VAS leg pain reduction of 40–60% at 4–6 weeks (Cochrane: modest benefit, limited beyond 3 months). Provides a 'window' for physiotherapy engagement.
• Selective nerve root block (SNRB): Diagnostic and therapeutic; identifies the symptomatic level when imaging is equivocal.

Pharmacological adjuncts: Gabapentin and pregabalin (neuropathic component); low-dose amitriptyline; duloxetine. Opioids are not recommended for chronic sciatica management due to poor evidence and dependency risk.

Natural history: 80–90% of lumbar disc herniations resorb spontaneously over 6–12 months via macrophage-mediated phagocytosis — with corresponding symptom resolution. Larger, sequestered fragments paradoxically resorb more completely than contained protrusions.